The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of bavituximab and sorafenib in advanced hepatocellular carcinoma (HCC).
 
Adam Charles Yopp
Speakers' Bureau - Bayer/Onyx
Research Funding - Peregrine Pharmaceuticals
 
Amit G. Singal
No Relationships to Disclose
 
Yull Edwin Arriaga
Consulting or Advisory Role - Bayer
 
Udit N. Verma
No Relationships to Disclose
 
Joseph Shan
Employment - Peregrine Pharmaceuticals
Leadership - Peregrine Pharmaceuticals
Stock and Other Ownership Interests - Peregrine Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Peregrine Pharmaceuticals
Travel, Accommodations, Expenses - Peregrine Pharmaceuticals
 
Nikoletta L. Kallinteris
Employment - Peregrine Pharmaceuticals
Stock and Other Ownership Interests - Peregrine Pharmaceuticals
Travel, Accommodations, Expenses - Peregrine Pharmaceuticals
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Celgene
Speakers' Bureau - Bayer/Onyx
Research Funding - Celgene; miRNA Therapeutics; Precision Biologics
 
John C. Mansour
No Relationships to Disclose
 
Hao Zhu
No Relationships to Disclose